ICH Project ICH6 held
November 21, 2003
About 1,850 participants attended ICH6 and all the sessions were completed
ICH6 was held at the Osaka International Convention Center in Nakanoshima, Kita-ku, Osaka City, for four days from November 12 to 15 under the theme "New Horizons and Future Challenges. The first day's satellite session was held at the Globes.
On the first day of the event, a satellite session entitled "Partnerships in Harmonisation" was held between the Global Cooperation Group (GCG) and non-ICH regions, where representatives from SADC, PANDRH, APEC, ASEAN, and other non-ICH regions gave reports and exchanged opinions. The symposium was titled "Partnerships in Harmonisation". The MedDRA Users' Group also met, and a workshop on Gene Therapy as a new technology discussed technical issues and problems in clinical trials.
On the second day, the opening plenary session was held, with a welcome speech by Mr. Mori, Vice Minister of Health, Labour and Welfare of Japan, followed by a speech by JPMA President Nagayama on behalf of the host country, entitled "New Era of Drug Discovery and Key Issues for Pharmaceutical Industry" in English. He stated that in Japan, the development of the infrastructure for pharmaceutical R&D, particularly the improvement of the clinical trial environment, is an urgent issue, and that the aim is to realize efficient and high-quality clinical trials. In Japan, the movement to promote life science and biotechnology as strategic national science and technology is in full swing. We must continue our efforts to create innovative new drugs and bring them to patients around the world. He emphasized that "we must continue our efforts to create innovative new drugs and deliver them to patients around the world.
Mr. Nagayama, JPMA Chairman, delivers his speech.
Dr. Lumpkin of FDA, Dr. Krall of PhRMA, Dr. Weissenverg of EU, and Prof. Herrling of EFPIA, representing each party of ICH, gave presentations on international regulatory harmonization efforts from the perspective of innovation in drug development. Prof. Herrling of EFPIA gave a presentation on innovation in drug development and international regulatory harmonization efforts.
On the third day, there was a Topic Breakout Session, in which presentations and discussions were made on the topics discussed and agreed upon at the Expert Meeting and Steering Committee Meeting held in Osaka prior to ICH6.
The closing plenary session was held on the 15th, the last day of the meeting, and included a summary of the ICH GCG and a discussion on the future of ICH as well as future challenges and predictions for drug development in the future due to the emergence of new technologies. ICH6 ended on a high note, with the participants confirming that ICH will continue to occupy an important position in the future, as the emergence of new technologies will make international collaboration increasingly necessary.
Closing Plenary Session